Complementary and alternative medicine use by patients receiving curative‐intent chemotherapy

No Thumbnail Available
File version
Author(s)
Smith, Peter J
Clavarino, Alexandra M
Long, Jeremy E
Anstey, Chris M
Steadman, Kathryn J
Primary Supervisor
Other Supervisors
Editor(s)
Date
2018
Size
File type(s)
Location

Perth, Australia

License
Abstract

Aims: To determine which types of complementary and alternative medicine (CAM) are being used by cancer patients commencing curative‐intent chemotherapy, whether the CAM taken has the potential to affect treatment efficacy, the reasons for patients’ decisions to use CAM and whether these patients would like information on CAM safety with chemotherapy.

Methods: Seventy‐five solid tumour malignancy patients receiving curative‐intent treatment attending a cancer care day unit were interviewed about their CAM use on the day of receiving their first dose of chemotherapy.

Results: Sixty percent of study participants were using CAM at the start of chemotherapy treatment. Biologically active CAM assessed as having potential to interact with prescribed chemotherapy was ingested by 27% of patients, all of whom had routinely used CAM prior to cancer diagnosis. CAM was used by 51% of patients for supportive care reasons and by 28% of patients with the intention of treating their cancer. Patients’ CAM decision‐making was influenced by advice from family and friends, practitioners, and from casual acquaintances. 13% of patients were told by a CAM advice‐giver not to have chemotherapy. The majority of patients (84%) would have liked to receive information on which CAM is safe to use with chemotherapy before treatment commenced.

Conclusions: Patients being treated with curative intent, particularly those with a history of CAM use, may be taking biologically‐active CAM with potential to compromise their chemotherapy treatment. These patients may be contending with alternative health advice to not have chemotherapy and want cancer‐care health professionals to provide them evidence‐based information on safe CAM use.

Journal Title
Conference Title

Asia-Pacific Journal of Clinical Oncology

Book Title
Edition
Volume

14

Issue

S7

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Oncology and carcinogenesis

Science & Technology

Life Sciences & Biomedicine

Persistent link to this record
Citation

Smith, PJ; Clavarino, AM; Long, JE; Anstey, CM; Steadman, KJ, Complementary and alternative medicine use by patients receiving curative-intent chemotherapy, Asia-Pacific Journal of Clinical Oncology, 2018, 14, pp. 170-170